Xingjuan Shi

1.4k citations
45 papers · 972 indexed · h-index 20
Topics
Microtubule and mitosis dynamics (13 papers)Ubiquitin and proteasome pathways (6 papers)Histone Deacetylase Inhibitors Research (5 papers)

In The Last Decade

Xingjuan Shi

41 papers receiving 965 citations

Peers

Xingjuan Shi
Comparison fields: 5 of 102
  • Molecular Biology 686
  • Cell Biology 283
  • Oncology 155
  • Cardiology and Cardiovascular Medicine 116
  • Genetics 103
Replace Yuko Hirota with:
Yuko Hirota Japan
Christopher M. Brennan United States
Jianqi Cui United States
Jongkyu Choi United States
Kristin B. Andersson Norway
Klara Valyi‐Nagy United States
C. David Wood United Kingdom
Guilherme Viteri United Kingdom
Ji-An Pan United States
Michael J. Munson United States
Xingjuan Shi relative to Yuko Hirota Japan Yuko Hirota's profile →
Citations per field
00.5×4.3×
Yuko Hirota · 1×
Citations per year

Countries citing papers authored by Xingjuan Shi

Since Specialization
Citations

This map shows the geographic impact of Xingjuan Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingjuan Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingjuan Shi more than expected).

Fields of papers citing papers by Xingjuan Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingjuan Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingjuan Shi. The network helps show where Xingjuan Shi may publish in the future.

Co-authorship network of co-authors of Xingjuan Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Xingjuan Shi. A scholar is included among the top collaborators of Xingjuan Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingjuan Shi. Xingjuan Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 0
3 0
4 0
5 0
6 7
7 1
8 1
9 20
10 31
11 30
12 18
13 15
14 17
15 47
16 14
17 65
18 33
19 40
20 28

About Xingjuan Shi

Xingjuan Shi is a scholar working on Cell Biology, Hepatology and Molecular Biology, having authored 45 papers that have together received 972 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (13 papers), Ubiquitin and proteasome pathways (6 papers) and Histone Deacetylase Inhibitors Research (5 papers). The work is most often cited by research in Cell Biology (283 citations), Virology (48 citations) and Molecular Biology (686 citations). Xingjuan Shi has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Jun Zhou, Dengwen Li, Xiaoou Sun, Xiaoou Sun, Min Liu, Ritu Aneja, Xiangdong Liu, Xiao‐Yan Wen, Lei Sun and Koroboshka Brand‐Arzamendi. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026